Erlotinib Completed Phase 1 Trials for Estrogen Receptor Breast Cancer / Non-Small Cell Lung Carcinoma (NSCLC) / Lung Cancers / Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01594398Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer